US 6028103
Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
expired A61PA61P35/00A61P43/00
Quick answer
US patent 6028103 (Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation) held by Ion Pharmaceuticals, Inc. expires Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Ion Pharmaceuticals, Inc.
- Grant date
- Tue Feb 22 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 42
- CPC classes
- A61P, A61P35/00, A61P43/00